跳至主要内容
临床试验/ISRCTN57101575
ISRCTN57101575已完成未知

Post-operative use of cell savers

Department of Health0 个研究点目标入组 0 人开始时间: 2004年9月30日最近更新:
适应症

试验速览

阶段
未知
状态
已完成

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Barts and the London NHS Trust patients

排除标准

  • Not provided at time of registration

研究者

相似试验

已完成
不适用
Does routine peri-operative continuous cell salvage in cardiac surgery reduce exposure to allogeneic blood? A randomised controlled trial
ISRCTN17615029Papworth Hospital NHS Trust (UK)206
尚未招募
不适用
Safety of IntraOperative Cell Salvage in visceral ONcologic surgeryvisceral cancer
DRKS00033355niversitätsklinikum Heidelberg300
尚未招募
Unknown
If a patient’s own blood is reinfused during major lifesaving cancer surgery, can modern technology reduce the risks of infection and cancer dissemination.intraoperative cell salvagepelvic exenteration surgerycolorectal cancer surgeryAnaesthesiology - AnaestheticsCancer - Bowel - Back passage (rectum) or large bowel (colon)Blood - Other blood disordersSurgery - Other surgery
ACTRN12624000167561Royal Brisbane and Women's Hosptial20
进行中(未招募)
1 期
Postoperative replacement of iron losses happening during and after an operatio
EUCTR2018-003184-65-ATVifor Pharma360
进行中(未招募)
1 期
Immediate or early salvage post-operative externalradiotherapy combined with concomitant and adjuvanthormonal treatment versus immediate or early salvage postoperative external radiotherapy alone in pT3a-b R0-1 cN0M0 / pT2R1 cN0M0, Gleason score 5-10 prostatic carcinoma. A Phase III studyProstatic carcinoma with pathological stage pT3a-b R0-1 N0M0 / pT2R1 N0M0, Gleason score 5-10MedDRA version: 14.0Level: LLTClassification code 10036955Term: Prostatic carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2006-002772-17-BEEuropean Organisation for Research and Treatment of Cancer600